{"id":"https://openalex.org/W3017143301","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.04021","title":"In vitro Reversal of Multidrug Resistance in Cancer","display_name":"In vitro Reversal of Multidrug Resistance in Cancer","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W3017143301","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.04021","mag":"3017143301"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.2020.34.s1.04021","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.04021","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.04021","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035048578","display_name":"Kasi L. Holcomb\u2010Webb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kasi L. Holcomb-Webb","raw_affiliation_strings":["Southern Methodist University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southern Methodist University","institution_ids":["https://openalex.org/I178169726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012226579","display_name":"Gabrielle E. Gard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabrielle E. Gard","raw_affiliation_strings":["Southern Methodist University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southern Methodist University","institution_ids":["https://openalex.org/I178169726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025846620","display_name":"Pia D. Vogel","orcid":"https://orcid.org/0000-0002-8135-4649","observed_orcids":["https://orcid.org/0000-0002-8135-4649"]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pia D. Vogel","raw_affiliation_strings":["Southern Methodist University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southern Methodist University","institution_ids":["https://openalex.org/I178169726"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084263586","display_name":"John G. Wise","orcid":"https://orcid.org/0000-0001-5398-8794","observed_orcids":["https://orcid.org/0000-0001-5398-8794"]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John G. Wise","raw_affiliation_strings":["Southern Methodist University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southern Methodist University","institution_ids":["https://openalex.org/I178169726"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I178169726"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"S1","first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9890000224113464},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.7680000066757202},{"id":"https://openalex.org/keywords/drug-efflux-pumps","display_name":"drug efflux pumps","score":0.7239999771118164},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.6819999814033508},{"id":"https://openalex.org/keywords/bcrp-inhibitors","display_name":"BCRP inhibitors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.75},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6959999799728394},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C512196","wikidata":"https://www.wikidata.org/wiki/Q4650095","display_name":"Abcg2","level":5,"score":0.8927015662193298},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.730714738368988},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.5894668698310852},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5654335021972656},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5575451254844666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5528881549835205},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5194756388664246},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.48927542567253113},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.48206692934036255},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.46089237928390503},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4568110704421997},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42042994499206543},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3835860788822174},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.25038886070251465},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1164047122001648},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.2020.34.s1.04021","doi":"https://doi.org/10.1096/fasebj.2020.34.s1.04021","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.2020.34.s1.04021","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.44999998807907104,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3023513074","https://openalex.org/W3017673553","https://openalex.org/W6996162330","https://openalex.org/W7161371626","https://openalex.org/W7110671747","https://openalex.org/W3173329506","https://openalex.org/W3177335019","https://openalex.org/W2979331237","https://openalex.org/W2076174476","https://openalex.org/W2055026383"],"abstract_inverted_index":{"Multi\u2010drug":[0],"resistance":[1],"(MDR)":[2],"occurs":[3],"when":[4],"cancer":[5,142,166,171],"cells":[6,131],"become":[7,35],"resistant":[8,36],"to":[9,22,29,37,75,78,94,97,130,135,156],"multiple":[10],"chemotherapeutic":[11],"drugs":[12,39],"that":[13,49],"are":[14],"functionally":[15],"and":[16,27,55,117,132,167,175,191,194,237,244,254],"structurally":[17],"different.":[18],"MDR":[19,77,137,196,213],"usually":[20],"leads":[21],"failure":[23],"of":[24,81,84,107,121,151,184,206,242,251,259],"chemotherapy":[25],"treatment":[26],"subsequently":[28],"poor":[30],"patient":[31],"prognosis.":[32],"Cancers":[33],"can":[34],"antineoplastic":[38],"by":[40,229],"over\u2010expressing":[41],"one":[42],"or":[43,70,222],"more":[44],"ATP\u2010binding":[45],"cassette":[46],"(ABC)":[47],"transporters":[48],"act":[50],"as":[51,91],"drug":[52],"efflux":[53],"pumps":[54],"expel":[56],"xenobiotics":[57],"from":[58,247],"cells.":[59],"One":[60],"such":[61],"protein":[62,192],"is":[63,73,88,219,227],"the":[64,133,139,152,162,182,195,230,239],"Breast":[65],"Cancer":[66],"Resistance":[67],"Protein":[68],"(BCRP,":[69],"ABCG2),":[71],"which":[72],"believed":[74],"confer":[76],"several":[79,104],"types":[80],"cancer.":[82],"Inhibition":[83],"BCRP":[85,108,122,154,163,185],"cellular":[86,118],"activity":[87],"therefore":[89],"thought":[90],"a":[92],"way":[93],"restore":[95],"sensitivity":[96],"chemotherapeutics.":[98],"In":[99],"previous":[100],"work,":[101],"we":[102,124,147],"identified":[103],"potential":[105,153],"inhibitors":[106,155,210],"using":[109,200],"high\u2010throughput":[110],"in":[111,138,214],"silico":[112],"screens.":[113],"Using":[114],"cell":[115,143,160,169,172,180,201,217],"viability":[116,202],"accumulation":[119],"assays":[120],"substrates,":[123],"assessed":[125,188],"these":[126,215],"compounds":[127],"for":[128,233],"toxicity":[129],"ability":[134],"reverse":[136],"BCRP\u2010overexpressing":[140,159],"breast":[141],"line,":[144,181],"MCF7\u2010M100.":[145],"Here":[146],"expand":[148],"our":[149,207],"studies":[150],"two":[157,216],"other":[158],"lines,":[161,173],"overexpressing":[164],"colon":[165],"non\u2010small":[168],"lung":[170],"S1M1\u201080":[174],"MX20,":[176],"respectively.":[177],"For":[178],"each":[179],"level":[183,193],"overexpression":[186],"was":[187,198],"at":[189],"RNA":[190],"phenotype":[197],"confirmed":[199],"assays.":[203],"The":[204],"effects":[205],"newly":[208],"discovered":[209],"on":[211],"reversing":[212],"lines":[218],"reported.":[220],"Support":[221],"Funding":[223],"Information":[224],"This":[225],"work":[226],"supported":[228],"SMU":[231],"Center":[232],"Drug":[234],"Discovery,":[235],"Design":[236],"Delivery,":[238],"Communities":[240],"Foundation":[241],"Texas,":[243,253],"private":[245],"gifts":[246],"Ms.":[248,255],"Suzy":[249],"Ruff":[250],"Dallas,":[252],"Myra":[256],"Williams,":[257],"Ph.D.,":[258],"Naples,":[260],"FL.":[261]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2020-04-24T00:00:00"}